Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Healthcare Nanotechnology (Nanomedicine) Market by Application, Disease and Geography - Forecast to 2024 - ResearchAndMarkets.com

April 17, 2019

DUBLIN--(BUSINESS WIRE)--Apr 17, 2019--The “Healthcare Nanotechnology (Nanomedicine) Market - Growth, Trends, and Forecast (2019 - 2024)” report has been added to ResearchAndMarkets.com’s offering.

The primary demand of this field in medicine is in making improvements in the delivery of treatments and healthcare outcomes. Nanomedicine refers to the usage of nanoscale healthcare technology in pharmaceutical applications to make medically useful products.

Nanomedicine is a promising mode of cancer treatment. This growing field of medical research can be used to discover a better-personalized treatment for a range of diseases, including cancers. With the advantage of the properties of matter at the nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

The need for technological advancements to enhance disease diagnosis, treatment, and prevention is the major driver for the nanomedicine market.

In the case of cancers, nanomedicine offers promising changes from the current methods of diagnosing and treating cancer. Translation of nano-based cancer therapies and diagnostics has witnessed significant progress and several new developments are in the pipeline. Along with these, multiple other factors are also driving the growth of this market in the healthcare industry.

Scope of the Report

As per the scope of the report, the healthcare nanotechnology (nanomedicine) market includes products that are nanoformulations of the existing drugs or new drugs or are nanobiomaterials.

The market is segmented by its application in the medical field, as drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications. The market is also segmented by its use in the treatment of diseases, like cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.

Key Market Trends

The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period

A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies.

The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimer’s disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.

Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.

North America is Expected to Hold the Largest Share in the Market

In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities.

Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role.

In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs.

In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.

Competitive Landscape

The major market players are focusing on technological advancements and improvements in drug bioavailability and drug administration. Some of the major players in the market are Sanofi, Pfizer, Celgene Corporation, Luminex Corporation, and Taiwan Liposome Company.

Key Topics Covered


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases

4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures

4.2.3 Growing Preference for Personalized Medicines

4.3 Market Restraints

4.3.1 High Cost

4.3.2 Stringent Regulations for Commercial Introduction

4.4 Porter’s Five Forces Analysis


5.1 By Application

5.1.1 Drug Delivery

5.1.2 Biomaterials

5.1.3 Active Implants

5.1.4 Diagnostic Imaging

5.1.5 Tissue Regeneration

5.1.6 Other Applications

5.2 By Disease

5.2.1 Cardiovascular Diseases

5.2.2 Oncological Diseases

5.2.3 Neurological Diseases

5.2.4 Orthopedic Diseases

5.2.5 Infectious Diseases

5.2.6 Other Diseases

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America


6.1 Company Profiles

6.1.1 Sanofi S.A.

6.1.2 Celegene Corporation

6.1.3 CytImmune Sciences Inc.

6.1.4 Johnson & Johnson

6.1.5 Luminex Corporation

6.1.6 Merck & Co. Inc.

6.1.7 Nanobiotix

6.1.8 Pfizer Inc.

6.1.9 Starpharma Holdings Limited

6.1.10 Taiwan Liposome Company Ltd.


For more information about this report visit https://www.researchandmarkets.com/r/fhdy6b

View source version on businesswire.com:https://www.businesswire.com/news/home/20190417005637/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Nanotechnology,Nanomedicine



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 04/17/2019 11:47 AM/DISC: 04/17/2019 11:47 AM


All contents © copyright 2019 The Associated Press. All rights reserved.